Abstract:Background It has been postulated that non-steroidal anti-inflammatory drugs (NSAIDs) use leads to decreased prostate cancer (PCa) risk. In recent years, NSAIDs’ role in PCa development has been extensively studied; however, there is not yet a definitive answer. Moreover, the epidemiological results for NSAIDs’ effect on PCa-specific mortality have been inconsistent. Therefore, we performed a meta-analysis to examine the controversy. Methods We performed a literature database search and included all published studies conducted in the general population exposed to any NSAID, extracting an odds ratio (OR) or a hazard ratio (HR) with 95% confidence intervals (95% CIs) that compared the incidence of PCa or PCa-specific mortality with non-exposure. We derived a pooled OR or HR using random or fixed effects models, as appropriate. Subgroup analyses were also performed. Results Thirty-nine studies (20 case–control and 19 cohort studies) were included in this analysis. Thirty-one studies were available concerning NSAID use and PCa incidence and eight studies on PCa-specific mortality. Compared to non-use, aspirin use was statistically significantly associated with PCa incidence risk, and the association was slightly stronger for advanced PCa than for total PCa (OR = 0.92, 95% CI = 0.87 to 0.97 for total PCa; OR = 0.81, 95% CI = 0.73 to 0.89 for advanced PCa). Aspirin use seems also to be associated with a modest reduction in PCa-specific mortality (HR = 0.86, 95% CI = 0.78 to 0.96 for total PCa; OR = 0.81, 95% CI = 0.71 to 0.92 for advanced PCa). Generally, the pooled effects for any NSAIDs, NA-NSAIDs and cyclooxygenase-2 inhibitors demonstrated no adverse or beneficial effects on PCa development or PCa-specific mortality, but the results were not consistent. The effect estimates did not vary markedly when stratified by study design and study quality but varied by geographic region. Furthermore, long-term aspirin use (≥4 years) was also significantly associated with reduced PCa incidence (OR = 0.88, 95% CI 0.79 to 0.99). Conclusions The present meta-analysis provides support for the hypothesis that aspirin use is inversely related to PCa incidence and PCa-specific mortality. The effect estimates, varying by geographic region, deserve further investigation.

Is aspirin use associated with age-related macular degeneration? A meta-analysis.

Association Between Aspirin Use and Age-Related Macular Degeneration: a Meta-Analysis.

Aspirin Use and Risk of Age-Related Macular Degeneration: A Meta-Analysis

Aspirin and Age Related Macular Degeneration; the Possible Relationship.

Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis

Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration

The Association Between Statin Use and Risk of Age-Related Macular Degeneration

Aspirin Use and Risk of Colorectal Cancer among Older Adults.

Association of aspirin with dementia or mild cognitive impairment: A systematic review and meta-analysis of randomized trials

Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies

Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials

Aspirin Use and Lung Cancer Risk: a Possible Relationship? Evidence from an Updated Meta-Analysis.

Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis

Aspirin Use and Endometrial Cancer Risk: a Meta-Analysis and Systematic Review

Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

Association of Aspirin Therapy with Prognosis in Patients with Non Obstructive Coronary Artery Disease: A Systematic Review and Meta-Analysis

Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis.

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis

Abstract MP30: Metabolomics Analyses Identified Factors Modifying the Association of Aspirin Use With Kidney Function

Aspirin intake is not associated with diabetic retinopathy and diabetic macular edema: A report from the Fushun diabetic retinopathy cohort study

Association of aspirin use with risk of intracerebral hemorrhage in patients without history of stroke or transient ischemic attack in the UK Biobank